Visualization of Efficacy of Recombinant Factor FVIIa in a Pelvic Fracture Patient

Journal of Trauma

Volumn 64, Issue 6, 2008, Pages E86-E88

  Noda, Mariko ^a   Morozumi, Junya ^a   Mishima, Shiro ^a   Sasaki, Hirokazu ^a   Yukioka, Tetsuo ^a   Ohta, Shoichi ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFICACY; ECHOGRAPHY; FALLING; FEMUR FRACTURE; FIRST AID; HEMATOCRIT; HEMATOMA; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PELVIS FRACTURE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTHROMBIN TIME; SACRUM; THROMBOCYTE COUNT; TREATMENT RESPONSE; ANGIOGRAPHY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; EMERGENCY HEALTH SERVICE; FOLLOW UP; FRACTURE; ILIAC ARTERY; INJURY; INJURY SCALE; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE TRAUMA; PELVIC GIRDLE; PHYSIOLOGY; RADIOGRAPHY; RISK ASSESSMENT; TREATMENT OUTCOME;

ACCIDENTAL FALLS; ADULT; ANGIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMBOLIZATION, THERAPEUTIC; FACTOR VIIA; FOLLOW-UP STUDIES; FRACTURES, BONE; HEMATOMA; HEMODYNAMICS; HUMANS; ILIAC ARTERY; INJECTIONS, INTRAVENOUS; INJURY SEVERITY SCORE; MALE; MULTIPLE TRAUMA; PELVIC BONES; RECOMBINANT PROTEINS; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED; TRAUMA CENTERS; TREATMENT OUTCOME;

EID: 67650337002     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/TA.0b013e318175d700     Document Type: Article

References (11)

1. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet. 1999;354:1879.
2. Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet. 2003;361:201-205.
3. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59:8-15.
4. Isbister J, Phillips L, Dunkley S, Jankelowitz G, McNeil J, Cameron P. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand haemostasis register. Intern Med J. 2008;38:156-165.
5. Rizoli SB, Boffard KD, Riou B, et al. Recombinant factor VII as an adjunctive therapy for bleeding control in severely trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care. 2006;10:R178.
6. Perkins JG, Schreiber MA, Wade CE, Holcomb JB. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. J Trauma. 2007;62:1095-1101.
7. American college of surgeons. Shock: Advanced Trauma Life Support for Doctors. 6th ed. Chicago, IL: American College of Surgeons; 1997:100.
8. Hagiwara A, Minakawa K, Fukushima H, Murata A, Masuda H, Shimazaki S. Predictors of death in patients with life-threatening pelvic hemorrhage after successful transcatheter arterial embolization. J Trauma. 2003;55:696-703.
9. Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost. 2001;27:585-592.
10. Gallistl S, Cvirn G, Muntean W. Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost. 1999;81:245-249.
11. Tobias JD, Berkenbosch JW, Muruve NA, Schmaltz RA. Correction of a coagulopathy using recombinant factor VII before removal of an intra-aortic balloon pump. J Cardiothorac Vasc Anesth. 2002;16:612-614.